Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. - Datoo MS; Dicko A; Tinto H; Ouédraogo JB; Hamaluba M; Olotu A; Beaumont E; Ramos Lopez F; Natama HM; Weston S; Chemba M; Compaore YD; et al. (Lancet (London, England), 2024)